1[1]Laufs U, Gertz K, Huang P, Nickenig G, Bohm M, Dimagl U, Endres M. Atorvastatin upregulates type Ⅲ nitric oxide synthase in thrombocytes,decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke, 2000,31 (10): 2442 - 49
2[2]Szczeklik A,Musial J,Undas A,Gajewski P,Gora P,Swadzba J,Jankowski M. Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia. J Am Coll Cardiol, 1999,33(5): 1286 - 93
3[3]Song JC, White CM. Do HMG-CoA reductase inhibitors affect fibrinogen?Ann Pharmacother,2001,35(2) :236 - 41
4[4]Gentile S,Turco S, Guarino G, Sasso CF, Amodio M, Magliano P, Salvatore T, Corigliano G, Agrusta M, De Simone G, Gaeta I, Oliviero B, Torella R.Comparative efficacy study of atorvastatin vs simvastatin, pravastatin,lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia. Diabetes Obes Metab, 2000,2 (6): 355 - 62
5[5]Bourcier T, Libby P. HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler Thromb Vase Biol, 2000,20 (2): 556 - 62
6[6]Jocelyn Dupuis. Mechanisms of acute coronary syndromes and the potential role of statins. Atherosclerosis, 2001,159( Suppl 2): 9 - 14
7[7]Maas AC, Green CL, Shah SA, et al. Incremental effects of antiplatelet,anti-thrombin and fibrinolytic therapy on the speed and stability of STsegment recovery after acute MI.J Am Coll Cardiol,2000,35(Suppl. A):372
8[8]Wallentin LC. Early cholesterol lowering treatment and early surgical intervention: balloon dilatation improves survival after myocardial infarction-landmark results from a largescale Scandinavian register. Oral presentation at XXII Annual Congress of the European Society of Cardiology,Amsterdam, The Nether-lands, August 26 - 30,2000
9[9]Schwartz,GC,Olsson AG,Ezekowitz MD,Ganz P,Oliver MF, Waters D,Zeiher A, Chaitman BR, Leslie S, Stern T, for the Myocardial lschemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL Study: a randomized controlled trial. JAMA,2001,285:1711 - 18.
10[10]Kayikcioglu M, Turkoglu C, Kultursay H, Harum H, Can L. Combined use of pravastatin and thrombolytic agents in acute myocardial infarction. Pravastatin Turkish Trial. Circulation, 1999,100( Suppl. I): 1 - 303
